Pasithea Therapeutics Corp (KTTA)
NASDAQ:KTTA
US Market

Pasithea Therapeutics Corp (KTTA) Financial Statements

29 Followers

Pasithea Therapeutics Corp Financial Overview

Pasithea Therapeutics Corp's market cap is currently ―. The company's EPS TTM is $-14.302; its P/E ratio is -0.41; Pasithea Therapeutics Corp is scheduled to report earnings on March 30, 2022, and the estimated EPS forecast is $-1.00. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ 4.22M$ -5.15M$ -3.61M$ -3.72M$ -3.26M
EBITDA$ 4.38M$ -4.99M$ -3.45M$ -3.55M$ -3.10M
Net Income Common Stockholders$ -3.86M$ -5.05M$ -3.61M$ -3.76M$ 3.16M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 12.00M$ 16.30M$ 19.70M$ 26.77M$ 29.91M
Total Assets$ 22.41M$ 26.12M$ 30.66M$ 38.15M$ 41.87M
Total Debt$ 32.99K$ 81.68K$ 385.29K$ 559.10K$ 729.56K
Net Debt$ -11.97M$ -16.22M$ -19.31M$ -26.21M$ -29.18M
Total Liabilities$ 2.52M$ 2.72M$ 2.28M$ 2.56M$ 2.91M
Stockholders Equity$ 19.88M$ 23.40M$ 28.37M$ 35.59M$ 39.14M
Cash Flow-
Free Cash Flow$ -4.32M$ -3.24M$ -2.60M$ -3.47M$ -3.42M
Operating Cash Flow$ -4.32M$ -3.29M$ -2.65M$ -3.50M$ -3.37M
Investing Cash Flow-$ 54.54K$ -273.65K$ 344.01K$ -49.70K
Financing Cash Flow--$ -3.86M$ -130.77K$ 264.10K
Currency in USD

Pasithea Therapeutics Corp Earnings and Revenue History

Pasithea Therapeutics Corp Debt to Assets

Pasithea Therapeutics Corp Cash Flow

Pasithea Therapeutics Corp Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis